Cargando…
IGFBP‐3 inhibits Wnt signaling in metastatic melanoma cells
In previous works, we have shown that insulin‐like growth factor‐binding protein‐3 (IGFBP‐3), a tissue and circulating protein able to bind to IGFs, decreases drastically in the blood serum of patients with diffuse metastatic melanoma. In agreement with the clinical data, recombinant IGFBP‐3 was fou...
Autores principales: | Naspi, Antimo, Zingariello, Maria, Sancillo, Laura, Panasiti, Vincenzo, Polinari, Dorina, Martella, Marianna, Rosa Alba, Rana, Londei, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5213668/ https://www.ncbi.nlm.nih.gov/pubmed/27377812 http://dx.doi.org/10.1002/mc.22525 |
Ejemplares similares
-
Insulin-Like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression In Vitro and In Vivo
por: Naspi, Antimo, et al.
Publicado: (2014) -
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells
por: Zalfa, Francesca, et al.
Publicado: (2017) -
eIF6 over-expression increases the motility and invasiveness of cancer cells by modulating the expression of a critical subset of membrane-bound proteins
por: Pinzaglia, Michela, et al.
Publicado: (2015) -
Inhibition of Eukaryotic Translation Initiation Factor 5A (eIF5A) Hypusination Suppress p53 Translation and Alters the Association of eIF5A to the Ribosomes
por: Martella, Marianna, et al.
Publicado: (2020) -
IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
por: Cai, Qing, et al.
Publicado: (2020)